{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:36:29Z","timestamp":1695573389407},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.jhep.2006.01.011","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T18:25:05Z","timestamp":1139423105000},"page":"633-636","source":"Crossref","is-referenced-by-count":9,"title":["Steroids or cocktails for alcoholic hepatitis"],"prefix":"10.1016","volume":"44","author":[{"given":"Robert","family":"O'Shea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur J.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2006.01.011_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cld.2004.11.004","article-title":"Treatment of alcoholic hepatitis","author":"O'Shea","year":"2005","journal-title":"Clin Liv Dis"},{"key":"10.1016\/j.jhep.2006.01.011_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.01.011_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis?","volume":"113","author":"Impteriale","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2006.01.011_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2006.01.011_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2006.01.011_bib6","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.01.011_bib7","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.1998.00587.x","article-title":"The American College of Gastroenterology position paper on the therapy of alcoholic liver disease","volume":"93","author":"McCullough","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2006.01.011_bib8","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2006.01.011_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double-blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.01.011_bib10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.01.011_bib11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-A randomized clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.01.011_bib12","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/01.ALC.0000168168.43419.54","article-title":"Modulation of oxidative stress by alcohol","volume":"29","author":"Zima","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2006.01.011_bib13","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1053\/gast.2003.50087","article-title":"Oxidants and anti-oxidants in alcohol-induced liver disease","volume":"124","author":"Arteel","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.01.011_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.20810","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"8","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.01.011_bib15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.01.011_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.20771","article-title":"Grading alcoholic hepatitis","volume":"42","author":"Forrest","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.01.011_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A randomized placebo controlled trial of Vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.01.011_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/07315724.1995.10718493","article-title":"Effects of long-term vitamin supplementation in alcoholic cirrhotics","volume":"14","author":"de la Maza","year":"1995","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jhep.2006.01.011_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2004-832937","article-title":"Diagnosis and therapy of alcoholic liver disease","volume":"24","author":"Levitsky","year":"2004","journal-title":"Semin Liv Dis"},{"key":"10.1016\/j.jhep.2006.01.011_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high dose Vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2006.01.011_bib21","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jama.285.9.1178","article-title":"Effects of vitamin E on lipid peroxidation in healthy persons","volume":"285","author":"Meagher","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2006.01.011_bib22","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0891-5849(00)00236-7","article-title":"Molecular action of Vitamin E in lipoprotein oxidation: implications for atherosclerosis","volume":"28","author":"Thomas","year":"2000","journal-title":"Free Radiol Biol Med"},{"key":"10.1016\/j.jhep.2006.01.011_bib23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/33308","article-title":"Vitamin C exhibits pro-oxidant properties","volume":"392","author":"Podmore","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2006.01.011_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0891-5849(99)00264-6","article-title":"Measurement of F(2) isoprostanes as an index of oxidative stress in vivo","volume":"28","author":"Roberts","year":"2000","journal-title":"Free Radiol Biol Med"},{"key":"10.1016\/j.jhep.2006.01.011_bib25","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1074\/jbc.272.3.1433","article-title":"Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima","volume":"272","author":"Leeuwenburgh","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2006.01.011_bib26","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1172\/JCI119379","article-title":"3-Chlorotyrosine, a specific marker of myeloperoxidase catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima","volume":"99","author":"Hazen","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2006.01.011_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.ALC.0000056688.27111.49","article-title":"Phagocytosis and production of reactive oxygen species by peripheral blood phagocytes in patients with different stages of alcohol-induced liver disease: effect of acute exposure to low ethanol concentrations","volume":"3","author":"Parlesak","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"issue":"27","key":"10.1016\/j.jhep.2006.01.011_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0741-8329(02)00212-4","article-title":"Monocyte activation in alcoholic liver disease","author":"McClain","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.jhep.2006.01.011_bib29","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1074\/jbc.275.8.5425","article-title":"Nitric oxide modulates the catalytic activity of myeloperoxidase","volume":"275","author":"Abu-soud","year":"2000","journal-title":"JBC"},{"key":"10.1016\/j.jhep.2006.01.011_bib30","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.0000097003.49585.5E","article-title":"Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia","volume":"108","author":"Tao","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2006.01.011_bib31","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.289.13.1675","article-title":"Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy","volume":"289","author":"Shishehbor","year":"2003","journal-title":"JAMA"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T15:40:09Z","timestamp":1586706009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827806000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0168827806000560"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2006.01.011","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}